Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
[Sarcoid neuropathy].
The Advances in Neurobiology.
A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
[Current and historical concept of neuromyelitis optica].
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
Autopsy-proven demyelination associated with infliximab treatment.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Albumin and multiple sclerosis.
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).

Pages